Benevolent News Hub

Our Senior Product Designer explores the design process at BenevolentAI where he builds user facing tools that help our scientists discover and develop new medicines.

For International Women’s Day we hosted a fireside chat with four of our female colleagues to learn about their experiences, successes and the challenges they've faced in a largely male dominated industry.

Sex differences have historically been neglected in clinical research, design and practice. For International Women’s Day, we explored the implications of this ‘one size fits all’ approach on women’s health.

The biomedical research data-gap risks worsening health inequality, and will be exacerbated in the age of AI. In a recent panel at Benevolent, technology and healthcare experts discussed the data diversity issue and proposed solutions.

We partnered with UC San Diego to investigate new approaches to develop non-invasive therapeutic treatments for CCM. Benevolent’s Senior Principal Scientist shares insights into his work to use AI to identify new targets associated with this disease.

We’re proud to be recognised on this prestigious list for our work in AI-driven chemical design. Our compound design is based upon complex multiparametric optimisations which aim to cut the time and cost of designing a drug.